Enhancement of Aqueous Solubility and Oral Bioavailability of Nelfinavir by Complexation with β-Cyclodextrin

被引:8
作者
Kumari, Shilpi [1 ]
Bhawar, Ganesh T. [2 ]
Musmade, Prashant B. [2 ]
Lewis, Shaila [1 ]
机构
[1] Manipal Univ, Manipal Coll Pharmaceut Sci, Dept Pharmaceut, Manipal 576104, Karnataka, India
[2] Manipal Univ, Manipal Coll Pharmaceut Sci, Dept Pharmaceut Qual Assurance, Manipal 576104, Karnataka, India
关键词
beta-Cyclodextrin; Nelfinavir mesylate; Inclusion complex; Freeze-drying; Bioavailability; Dissolution; Kneading; DISSOLUTION; ABSORPTION; DRUGS;
D O I
10.4314/tjpr.v14i8.3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: To determine if complexation with beta-cyclodextrin (beta-CD) increases water solubility and subsequent bioavailability of nelfinavir mesylate (NM). Methods: Complexation of NM with beta-CD in 1: 1.5 molar ratio was carried out by solvent evaporation, freeze-drying and kneading methods. The complexes were characterized by Fourier transform infrared spectroscopy (FTIR). The in vitro solubility of the pure drug as well as that of the complexes was evaluated using USP type 2 apparatus. One of the drug complexes was also evaluated in vivo using Wistar rats to determine its pharmacokinetic profile. Results: Freeze-dried NM-beta CD complex was selected for in vivo studies based on its free flowing property and superior texture. The complexes prepared by the three methods all showed largely similar dissolution rate. The in vivo pharmacokinetic study of the freeze-dried complex in male Wistar rats showed significant increase in Cmax, tmax and AUC (p <= 0.05) compared to those of the plain drug. Conclusion: These findings suggest that complexation of NM with beta-CD is an effective and promising approach to increasing the oral bioavailability of NM.
引用
收藏
页码:1333 / 1340
页数:8
相关论文
共 20 条
  • [1] Effect of β-cyclodextrin and hydroxypropyl β-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir
    Aleem, Omair
    Kuchekar, Bhanudas
    Pore, Yogesh
    Late, Sameer
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 47 (03) : 535 - 540
  • [2] Dissolution Testing for Generic Drugs: An FDA Perspective
    Anand, Om
    Yu, Lawrence X.
    Conner, Dale P.
    Davit, Barbara M.
    [J]. AAPS JOURNAL, 2011, 13 (03): : 328 - 335
  • [3] Some important considerations in the use of cyclodextrins
    Blanchard, J
    Proniuk, S
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (12) : 1796 - 1798
  • [4] The utility of cyclodextrins for enhancing oral bioavailability
    Carrier, Rebecca L.
    Miller, Lee A.
    Ahmed, Mran
    [J]. JOURNAL OF CONTROLLED RELEASE, 2007, 123 (02) : 78 - 99
  • [5] THE EFFECTS OF CYCLODEXTRINS ON DRUG ABSORPTION .1. INVITRO OBSERVATIONS
    FRIJLINK, HW
    SCHOONEN, AJM
    LERK, CF
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 49 (02) : 91 - 102
  • [6] Higuchi T.K.A.C., 1965, ADV ANAL CHEM INSTRU, V4, P117, DOI DOI 10.1016/S0076-6879(82)87029-8
  • [7] Hiremanth SN, 2008, J PHARM RES HEAL CAR, V2, P279
  • [8] Katzung BG, 2002, BASIC CLIN PHARM, P855
  • [9] Cyclodextrins
    Kurkov, Sergey V.
    Loftsson, Thorsteinn
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 453 (01) : 167 - 180
  • [10] Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system
    Lindenberg, M
    Kopp, S
    Dressman, JB
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (02) : 265 - 278